BioSpace News Archive

Danaher Corporation (NYSE: DHR) (the “Company”) announced today that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion.

MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) (the “Company”), a leading biotech company developing psychedelic-inspired therapies, has announced the addition of Dr. Peter Bergethon, a world-leading expert in neurology, digital medicine, and central nervous system (CNS) drug development to the Company’s Scientific Advisory Board.

Fully funded by the Canadian Institute of Health Research (CIHR), this multi-site clinical trial will take place at Toronto’s University Health Network (UHN) and Braxia’s CRTCE Research Clinic.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today updated its full year 2021 financial guidance to incorporate the GW Pharmaceuticals (GW) business.

Zhaoke Ophthalmology has obtained exclusive rights for the development and commercialization of PAN-90806 in Greater China, South Korea, and 10 ASEAN countries

Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal first quarter 2022 financial results on Thursday, July 8, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Surrozen Inc. announced today that data from preclinical studies were presented in four oral Abstract Flash Talk presentations during The Liver Biology Conference.

Entera Bio Ltd. today announced the European Patent Office has granted a patent titled “Methods and Compositions for Oral Administration of Proteins”

Vor Biopharma announced that it will build-out an in-house clinical manufacturing facility in Cambridge, Massachusetts to support its development of potentially transformative engineered hematopoietic stem cell and chimeric antigen receptor T-cell therapeutic candidates for patients with hematological malignancies.

Revive Therapeutics Ltd. is pleased to announce it has entered into an agreement with the University of Health Sciences Antigua to collaborate on utilizing Revive’s novel psychedelic-assisted therapies and pioneering the clinical research and development of psychedelics in Antigua and Barbuda.